Company Overview and Strategy - Aclaris is developing therapeutic franchises to address gaps in important Immune and Inflammatory (I&I) diseases, focusing on patient-driven innovation [1, 8] - The company anticipates having three clinical programs in 2025 and four in 2026, with 2026 being an important year for potential inflection points [11] - Aclaris expects its cash runway to extend into the second half of 2028, supporting its preclinical and clinical development plans [11, 14] Pipeline and Programs - Aclaris's pipeline includes Bosakitug (ATI-045), a monoclonal antibody targeting TSLP, ATI-052, a bispecific antibody targeting both TSLP and IL-4Rα, and ATI-2138, an oral inhibitor of ITK/JAK3 [14] - ATI-2138's Phase 2a open-label trial in Atopic Dermatitis (AD) achieved primary and key secondary endpoints, validating ITK as a therapeutic target; at week 12, 63% of patients experienced a ≥4-point improvement in worst itch [14, 103] - Bosakitug is currently in a two-arm placebo-controlled Phase 2 trial, while ATI-052 is in a Phase 1a/1b SAD MAD program with ongoing dosing [14] - The company is developing next-generation ITK selective inhibitors and bispecific antibodies, with potential for IND submissions starting in 2026 [14, 61] Market Opportunity and Technology - The total addressable market for select Th1, Th2, and Th17-mediated diseases is projected to be in the range of $0 to $70 billion globally from 2028-2034 [16] - Aclaris is leveraging its KINect® Technology Platform to target approximately 60% of the Kinome, with the annual sales of kinase drugs in 2024 at $62.8 billion and a market opportunity of $88.6 billion in 2029 [28, 30] - The global healthcare spending in autoimmune diseases in 2024 was $215 billion, with a global AI disease therapeutics market opportunity of $396 billion by 2030 [38] - Multi-specific antibodies had annual sales of $12.6 billion in 2024, highlighting an opportunity for best-in-class multi-specific antibodies for autoimmune and inflammatory diseases [38]

Financial Performance - BlackRock's Assets Under Management (AUM) reached $135 trillion as of September 30, 2025[2] - Q3 2025 Base Fees and Securities Lending Revenue amounted to $50 billion[2] - Q3 2025 Operating Income, as adjusted, was $2621 million[9] - Q3 2025 Net Income, as adjusted, reached $1907 million[11] - Q3 2025 EPS, as adjusted, was $1155[11] Net Flows - Total BlackRock experienced net inflows of $22 billion in Q3 2025[5] - ETFs Long-term net inflows were $153 billion in Q3 2025[5] Revenue Breakdown - Base fees constituted 75% of the quarterly revenue[23] - Securities lending revenue accounted for 1% of the quarterly revenue[23] - Performance fees represented 8% of the quarterly revenue[23] - Tech services & subscription revenue made up 8% of the quarterly revenue[23] Expense Analysis - Employee compensation and benefits represented 43% of the adjusted quarterly expenses[33] - General & administration expenses accounted for 17% of the adjusted quarterly expenses[33] Alternatives - Alternatives Fee-Paying AUM was $663 billion in Q3 2025[38]

CEO Introduction Shauna McIntyre October 2025 Safe Harbour Statement This presentation includes "forward-looking" statements, including, without limitation, projections and expectations regarding Ensurge and its subsidiaries (the "Group") and its future financial position, business strategy, plans and objectives (the "Forward-looking Statements"). All Forward-looking Statements included herein are based on information available to the Group, and views and assessments of the Group, as of the date of this pre ...

Financial Performance - Ericsson's organic sales decreased by 2% year-over-year in Q3 2025 [6] - The adjusted gross margin was 48.1% in Q3 2025 [6] - The adjusted EBITA margin was 14.7% in Q3 2025, excluding a SEK 7.6 billion capital gain from the iconectiv divestment [6, 9] - Free cash flow before M&A was SEK 6.6 billion in Q3 2025 [14] Sales Development by Market Area - Americas net sales were SEK 19.8 billion, with an organic growth decline of 8% [10] - Europe, Middle East, and Africa net sales were SEK 16.7 billion, with an organic growth of 3% [10] - South East Asia, Oceania, and India net sales were SEK 7.1 billion, with an organic growth of 1% [10] - North East Asia net sales were SEK 3.8 billion, with an organic growth of 10% [10] Segment Performance - Networks segment experienced a 5% organic sales decline [24] - Cloud Software and Services segment achieved 9% organic sales growth [28] - Enterprise segment experienced a 7% organic sales decline [31]

Ajinomoto Group's Latin America Strategy - The Ajinomoto Group aims to enhance corporate value in Latin America by focusing on Food and Bio & Fine Chemicals businesses, accelerating sustainability efforts with "AminoScience," and promoting organic growth and new business development[3] - The Latin America Division is structured around Brazil and Peru, with headquarters flexibly managing regional operations[4] Ajinomoto do Brasil (ABR) Overview - ABR's FY2024 sales amounted to approximately 3500 million BRL (approximately 100 billion JPY), contributing to the Ajinomoto Group's total sales of 1530 billion JPY[39] - ABR's sales composition in FY2024 was approximately 50% Food, 30% Food Ingredients & Agriculture (FI & Agri), and 20% Bio & Fine Chemicals (BF)[43] - ABR's Food business is experiencing steady expansion, with a CAGR of 9% from FY2018 to FY2024, driven by the strong growth of the Seasonings segment[53, 54] Market Presence and Growth - Tempero SAZÓN® flavor seasoning holds approximately 70% market share in Brazil, with a brand recognition rate of 96%[21, 64] - AJI-NO-MOTO® umami seasoning has approximately 98% recognition rate in Brazil[21] - Peru's Aji-no-men® instant noodles and Doña Gusta® flavor seasoning have approximately 98% and 80% market share, respectively[21] - Sales in Latin America are forecasted to reach approximately 125 billion JPY in FY2024, with CAGR from FY2018-2024 of 8% in Brazil, 14% in Peru and 18% in other neighboring countries[19] Sustainability and Innovation - ABR is participating in the "Recovery of Degraded Pasture Verification Study" to contribute to environmental and societal well-being through its Agri business[79] - AjiProTM-L initiatives in Brazil aim to reduce GHG emissions by approximately 1 t-CO2 eq per head per year and lower feed costs by approximately $100 per head per year[92] - ABR is actively engaged in Digital Transformation (DX) initiatives across all areas, including the implementation of AI, with Sales 6X YoY in FY2024[107, 108]

Financial Performance - 3Q25 net sales increased by 117% due to market share gains from key account strategy and new contract signings[6] - Earnings per share (EPS) in 3Q25 improved 123% to $029 from $026 in 3Q24[13] - The company declared a $022 dividend payable in 4Q25 and expects to return over $1 billion in dividends to shareholders in 2025[15] - 3Q25 operating cash flow (OCF) was $3869 million, representing 1153% of net income[34] Sales and Customer Metrics - Daily Sales Rate (DSR) growth for 3Q25 was 117%[6] - Customer sites with sales over $10K/month accounted for 821% of sales in 3Q25, up from 794% in 3Q24[6] - The number of customer sites with sales over $50K/month grew by 154%[6] Technology and Digital Footprint - The installed base of weighted FMI (Fastenal Managed Inventory) devices increased by 87% from 3Q24, reaching 133910 devices[20] - Activity through the FMI technology platform represented 453% of sales in 3Q25, compared to 430% in 3Q24[20] - Sales through the Digital Footprint (FMI technology plus non-FMI-related eBusiness) accounted for 613% of total sales in 3Q25[21] Margins and Expenses - Gross profit margin increased to 453% in 3Q25 from 449% in 3Q24[31] - Operating margin improved to 207% in 3Q25 from 203% in 3Q24, resulting in an incremental margin of 239%[15] - Employee-related expenses increased by 129% in 3Q25 compared to 3Q24[15]

Transaction Overview - OPAP public shareholders are expected to have a 215% economic ownership in the combined company[36] - The transaction is conditional on the shareholders who validly exercise the exit right not representing more than 5% of OPAP's total paid-up share capital[36] - A €080 dividend is payable shortly after completion of the transaction, in lieu of the remaining dividend for the financial year 2025[36] Allwyn's Financial Performance - Allwyn has a €19 billion pro forma Adjusted EBITDA with a 37% pro forma Adjusted EBITDA margin[55] - Allwyn's pro forma online NGR is 55%[55] - Allwyn's Net Revenue, Adjusted EBITDA and Adjusted EBITDA – Capex have all more than doubled since 2019[64] Growth and Diversification - The combined company is projected to have a double-digit EBITDA CAGR from 2024 to 2026[105] - The combined company will have increased strategic optionality and diversified risk, with geographic revenue splits including 28% from Greece and Cyprus, 15% from Austria, 13% from the United Kingdom, 13% from the Czech Republic, 6% from Italy, 4% from the United States, and product revenue splits including 39% from Lottery, 19% from Sports Betting, 18% from iGaming, 10% from VLTs and Casinos, and 14% from DFS[115] Financial Guidance - The financial guidance includes the acquisition of 510% of Novibet in early 2026 and ~623% of PrizePicks in H1-26, for which closing is subject to regulatory and antitrust approvals[128] - The company projects a medium-term Adjusted EBITDA margin of slightly higher than 40%[130]

Strategic Priorities - ANZ aims to win the preference of customers, shareholders, and the community by focusing on customer-centric strategies, simplicity, resilience, and value delivery[16, 34, 74] - The company's immediate priorities include embedding the new leadership team, integrating Suncorp Bank faster, accelerating the delivery of ANZ Plus, reducing duplication, and enhancing non-financial risk management[24] - ANZ plans to upgrade 8 million retail customers in Australia to the ANZ Plus front-end by September 2027[29] Financial Targets and Synergies - ANZ anticipates achieving full run-rate synergies of $500 million from Suncorp Bank by FY29[68, 71] - The company estimates gross cost savings of $800 million to be delivered in FY26[68, 71] - ANZ aims to increase Return on Tangible Equity (ROTE) from 10.3% in FY24 towards 12% by FY28 and towards 13% by FY30[68, 71] - The company targets a cost-to-income ratio in the mid-40s percent by FY28 and sustained through to FY30[68, 71] Business Model - ANZ has a diversified business model with two scale markets and two market-leading positions[12] - The company has approximately 8 million retail customers and 700,000 commercial customers[13] - ANZ is the 1 Institutional Bank across Australia, New Zealand, and Asia for relationship strength & quality[13]

PORSCHE Pre-Close Call Q3 2025 S T U T T G A R T , O C T O B E R 1 0 DR. ING. H.C. F. PORSCHE AG 1 Disclaimer Following our Q3 sales release on October 9th 2025, the Q3 Pre-Close call aims to provide all analysts and investors with the contents of that sales release, the most recent management statements at roadshows, conferences, and events. We also refer to the relevant messages from the H1 2025 earnings call and relevant public statements that we have made in the interim period. The remarks, comments and ...

Runway Growth Finance Corp. Overview of Proposed Acquisition of SWK Holdings NASDAQ Listed I RWAY I RWAYL I RWAYZ October 2025 © Runway Growth Capital LLC 2025 Forward-looking Statements This presentation dated October 2025 is being provided by Runway Growth Finance Corp. ("Runway Growth" or the "Company") for discussion purposes only and is neither an offer to sell, nor a solicitation of an offer to purchase, an interest in the Company. It is solely intended to describe the general business, investment obj ...